Marie Angela Mattson
Known title: DirectorCIK: 0002026387
Associated companies
Transaction History
| WRB | ▲ Buy | Grant | 3,090 | $0 | 6/3/2026 | View on chart |
| WRB | ▲ Buy | Grant | 2,776 | $0 | 6/11/2025 | View on chart |
| WRB | ▲ Buy | Grant | 2,534 | $0 | 6/12/2024 | View on chart |
| WRB | ▲ Buy | Grant | 3,090 | $0 | 6/3/2026 | View on chart |
| WRB | ▲ Buy | Grant | 2,776 | $0 | 6/11/2025 | View on chart |
| WRB | ▲ Buy | Grant | 2,534 | $0 | 6/12/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
W.R. Berkley Eyes Earnings Beat in Q3
W.R. Berkley is expected to post a Q3 earnings beat, with analysts highlighting key metrics such as reserve gains and investment income. The company’s performance is being closely watched as part of the broader insurance earnings season. Investors are noting the firm’s solid fundamentals, including a trailing P/E of 14.3 and a dividend yield of 0.54%.
W.R. Berkley Eyes Earnings Beat in Q3. W.R. Berkley is expected to post a Q3 earnings beat, with analysts highlighting key metrics such as reserve gains and investment income. The company’s performance is being closely watched as part of the broader insurance earnings season. Investors are noting the firm’s solid fundamentals, including a trailing P/E of 14.3 and a dividend yield of 0.54%.